拉波特治疗
RAPP
27.57
-2.00
-6.76%
拉波特治疗
US · RAPP
#2970 按市值排名
上市于 2024
27.57
-2.00
-6.76%
实时 - 追踪5344个代码 - 心跳于491秒前
· 2026-10-16 19:55
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 107.82% -0.04pp
- 机构数量
- 187
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund54.13%
VC/PE Fund33.97%
Hedge Fund14.16%
Public Company4.47%
Individual/Insider4.06%
Private Company0.43%
Insurance Company0.39%
Government Pension Fund0.22%
主要股东 截至 2026-06-30
Third Rock Ventures, LLC
15.11% · 7.25M 股
FMR
14.95% · 7.17M 股
Arch Venture Partners, L.P.
7.77% · 3.73M 股
Capital Research
7.24% · 3.47M 股
BlackRock
5.63% · 2.70M 股
Cormorant Asset Management, LP
5.54% · 2.66M 股
Sofinnova Investments, Inc.
3.97% · 1.90M 股
Johnson & Johnson Innovation - JJDC, Inc.
3.72% · 1.78M 股
The Goldman Sachs Group, Inc.
3.47% · 1.66M 股
Polar Capital Holdings Plc
3.35% · 1.61M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 16次买入 · 34次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Third Rock Ventures, LLC | -- | 15.11% |
| Abraham Ceesay | CEO, President, Treasurer & Director | 1.17% |
| Steven Paul | Founder & Independent Chairman | 1.08% |
| David Bredt | Founder, Chief Scientific Officer & Director | 0.82% |
| Swamy Yeleswaram | Chief Development Officer | 0.41% |
| Cheryl Gault | Chief Operating Officer | 0.28% |
| Bradley Galer | Chief Medical Officer | 0.23% |
| Reid Huber | Director | 0.04% |
| Troy Ignelzi | Chief Financial Officer | 0.02% |
| Wendy Young | Officer | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-29 | Cheryl Gault | Chief Operating Officer | Automatic Disposition | -10,000 | $33.04–33.76 |
| 2026-09-22 | Abraham Ceesay | CEO, President, Treasurer & Director | Automatic Disposition | -2,210 | $39.05–41.05 |
| 2026-09-07 | Abraham Ceesay | CEO, President, Treasurer & Director | Automatic Disposition | -8,210 | $45.56–46.01 |
| 2026-08-24 | Abraham Ceesay | CEO, President, Treasurer & Director | Automatic Disposition | -18,921 | $49.57 |
| 2026-08-24 | Swamy Yeleswaram | Chief Development Officer | Automatic Disposition | -50,160 | $50.00–51.06 |
| 2026-08-18 | Swamy Yeleswaram | Chief Development Officer | Automatic Disposition | -404 | $49.90 |
| 2026-08-10 | Abraham Ceesay | CEO, President, Treasurer & Director | Automatic Disposition | -51,499 | $45.97–48.62 |
| 2026-07-26 | Abraham Ceesay | CEO, President, Treasurer & Director | Automatic Disposition | -2,210 | $42.11–42.74 |
| 2026-07-13 | Abraham Ceesay | CEO, President, Treasurer & Director | Automatic Disposition | -8,210 | $39.72–40.57 |
| 2026-06-29 | Cheryl Gault | Chief Operating Officer | Automatic Disposition | -10,000 | $40.09–43.15 |
| 2026-06-28 | Abraham Ceesay | CEO, President, Treasurer & Director | Automatic Disposition | -8,220 | $39.77–40.34 |
| 2026-06-09 | John Michael Maraganore | Independent Director | Other Derivative Acquisition | +15,200 | $35.21 |
| 2026-06-09 | James Healy | Independent Director | Other Derivative Acquisition | +15,200 | $35.21 |
| 2026-06-09 | Steven Paul | Founder & Independent Chairman | Other Derivative Acquisition | +15,200 | $35.21 |
| 2026-06-09 | Robert Perez | Director | Other Derivative Acquisition | +15,200 | $35.21 |
| 2026-06-09 | Paul Silva | Director | Other Derivative Acquisition | +15,200 | $35.21 |
| 2026-06-09 | Reid Huber | Director | Other Derivative Acquisition | +15,200 | $35.21 |
| 2026-06-09 | Raymond Sanchez | Director | Other Derivative Acquisition | +15,200 | $35.21 |
| 2026-06-09 | Wendy Young | Officer | Other Derivative Acquisition | +15,200 | $35.21 |
| 2026-05-25 | Third Rock Ventures, LLC | -- | Automatic Disposition | -18,572 | $40.05 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:55:49 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
拉波特治疗 讨论区 0 条评论